Sulforaphane Increases p21 protein in Oral Cancer 67 795–804, 2000. [26] Verhoeven, D.T., Goldbohm, R.A., van Poppel, G., Verhagen, H., and van den Brandt, P.A.: Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol. Biomarkers Prev., 5, 733–748, 1996. [27] Zhang, S.M., Hunter, D.J., Rosner, B.A., Giovannucci, E.L., Colditz, G.A., Speizer, F.E., and Willett, W.C.: Intakes of fruits, vegetables, and related nutrients and the risk of non- Hodgkin’s lymphoma among women. Cancer Epidemiol. Biomarkers Prev., 9, 477–485, 2000. [28] Jo, E.H., Kim, S.H., Ahn, N.S., Park, J.S., Hwang, J.W., Lee, Y.S., and Kang, K.S.: Efficacy of sulforaphane is mediated by p38 MAP kinase and caspase-7 activations in ER-positive and COX-2-expressed human breast cancer cells. Eur. J. Cancer Prev., 16, 505–510, 2007. [29] Shankar, S., Ganapathy, S., and Srivastava, R.K.: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin. Cancer Res., 14, 6855–6866, 2008. [30] Yao, H., Wang, H., Zhang, Z., Jiang, B.H., Luo, J., and Shi, X.: Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int. J. Cancer, 123, 1255–1261, 2008. [31] Matsui, T.A., Murata, H., Sakabe, T., Sowa, Y., Horie, N., Nakanishi, R., Sakai, T., and Kubo, T.: Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. Oncol. Rep., 18, 1263–1268, 2007. [32] Singh, S.V., Herman-Antosiewicz, A., Singh, A.V., Lew, K.L., Srivastava, S.K., Kamath, R., Brown, K.D., Zhang, L., and Baskaran, R.: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phospho- rylation of cell division cycle 25C. J. Biol. Chem., 279, 25813–25822, 2004. [33] Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J.: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805–816, 1993. [34] Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P., and Massague, J.: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59– 66, 1994. [35] Parnaud, G., Li, P., Cassar, G., Rouimi, P., Tulliez, J., Combaret, L., and Gamet-Payrastre, L.: Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer, 48, 198–206, 2004. [36] Shen, G., Xu, C., Chen, C., Hebbar, V., and Kong, A.N.: p53- independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol., 57, 317–327, 2006. [37] Bouwman, P. and Philipsen, S.: Regulation of the activity of Sp1-related transcription factors. Mol. Cell Endocrinol., 195, 27–38, 2002. [38] Lania, L., Majello, B., and De Luca, P.: Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol., 29, 1313–1323, 1997. [39] Gartel, A.L. and Tyner, A.L.: Transcriptional regulation of the p21 ((WAF1/CIP1)) gene. Exp. Cell Res., 246, 280–289, 1999. [40] El-Deiry, W.S., Tokino, T., Velculesco, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E.W., Kinzler, K.W., and Vogelstain, B.: WAF1, a potential mediator of p53 suppression. Cell, 75, 817–825, 1993. [41] Baus, F., Gire, V., Fisher, D., Piette, J., and Dulic, V.: Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J., 22, 3992–4002, 2003. [42] Dulic, V., Stein, G.H., Far, D.F., and Reed, S.I.: Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M -phase transition. Mol. Cell Biol., 18, 546–557, 1998. [43] Traka, M.H., Chambers, K.F., Lund, E.K., Goodlad, R.A., Johnson, I.T., and Mithen, R.F.: Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21(waf1/ cip1). Nutr. Cancer, 61, 137–145, 2009. Vol. 46, No. 1, 2010